{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:28:00Z","timestamp":1786591680389,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Projects of Ege University","award":["22277"],"award-info":[{"award-number":["22277"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01159-3","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:55:46Z","timestamp":1780696546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous diazepam application in a departmental convulsive status epilepticus protocol with CYP2C19 polymorphisms: a pediatric prospective cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Muazzez","family":"Seker Gezici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durdugul","family":"Ayyildiz Emecen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Kanmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Yurtseven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Atik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanem Keskin","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Tekgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eylem Ulas","family":"Saz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"4","key":"1159_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522\u201330. https:\/\/doi.org\/10.1111\/epi.13670.","journal-title":"Epilepsia"},{"issue":"1","key":"1159_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48\u201361. https:\/\/doi.org\/10.5698\/1535-7597-16.1.48.","journal-title":"Epilepsy Curr"},{"issue":"1","key":"1159_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40268-021-00375-y","volume":"22","author":"LL Wang","year":"2022","unstructured":"Wang LL, Ren XX, He Y, Cui GF, Liu JJ, Jia J, et al. Pharmacokinetics of Diazepam and Its Metabolites in Urine of Chinese Participants. Drugs R D. 2022;22(1):43\u201350. https:\/\/doi.org\/10.1007\/s40268-021-00375-y.","journal-title":"Drugs R D"},{"issue":"4","key":"1159_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/0091270007311572","volume":"48","author":"C Lehmann","year":"2008","unstructured":"Lehmann C, Wannarka GL. Bioavailability and Dose Proportionality of Intramuscular Diazepam Administered by Autoinjector. J Clin Pharmacol. 2008;48(4):436\u201344. https:\/\/doi.org\/10.1177\/0091270007311572.","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"1159_CR5","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/epi.17041","volume":"62","author":"JW Wheless","year":"2021","unstructured":"Wheless JW, Miller I, Hogan RE, Dlugos D, Biton V, Cascino GD, et al. Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy. Epilepsia. 2021;62(10):2485\u201395. https:\/\/doi.org\/10.1111\/epi.17041.","journal-title":"Epilepsia"},{"issue":"11","key":"1159_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/psp4.12349","volume":"7","author":"LC Ku","year":"2018","unstructured":"Ku LC, Hornik CP, Beechinor RJ, Chamberlain JM, Guptill JT, Harper B, et al. Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus. CPT Pharmacometrics Syst Pharmacol. 2018;7(11):718\u201327. https:\/\/doi.org\/10.1002\/psp4.12349.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"1159_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/jpm13020285","volume":"13","author":"TT Ho","year":"2023","unstructured":"Ho TT, Noble M, Tran BA, Sunjic K, Gupta SV, Turgeon J, et al. Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome. J Pers Med. 2023;13(2):285. https:\/\/doi.org\/10.3390\/jpm13020285.","journal-title":"J Pers Med"},{"key":"1159_CR8","doi-asserted-by":"publisher","unstructured":"Zubiaur P, Figueiredo-Tor L, Villapalos-Garc\u00eda G, Soria-Chacartegui P, Navares-G\u00f3mez M, Novalbos J, Matas M, Calleja S, Mej\u00eda-Abril G, Rom\u00e1n M, Ochoa D, Abad-Santos F. Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam. Biomed Pharmacother. 2022;155:113747. https:\/\/doi.org\/10.1016\/j.biopha.2022.113747. Epub 2022 Sep 24. PMID: 36162369.","DOI":"10.1016\/j.biopha.2022.113747"},{"issue":"3","key":"1159_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bja.2021.10.029","volume":"128","author":"D Vodovar","year":"2022","unstructured":"Vodovar D, Chevillard L, Caill\u00e9 F, Ris\u00e8de P, Pottier G, Auvity S, et al. Mechanisms of respiratory depression induced by the combination of buprenorphine and diazepam in rats. Br J Anaesth. 2022;128(3):584\u201395. https:\/\/doi.org\/10.1016\/j.bja.2021.10.029.","journal-title":"Br J Anaesth"},{"issue":"1","key":"1159_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.35975\/apic.v28i1.2380","volume":"28","author":"T Mittal","year":"2024","unstructured":"Mittal T, Badhe VK, Divekar Badhe DS, Ahluwalia PP, Mittal B, Mittal R. Effect on Emergence from Anesthesia Following Induction with Diazepam and Its Association with CYP2C9, CYP2C19 and CYP3A4 Gene Polymorphisms. Anaesth Pain Intensive Care. 2024;28(1):126\u201338. https:\/\/doi.org\/10.35975\/apic.v28i1.2380.","journal-title":"Anaesth Pain Intensive Care"},{"issue":"1","key":"1159_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cpt.583","volume":"102","author":"B Moriyama","year":"2017","unstructured":"Moriyama B, Obeng AO, Barbarino J, Penzak SR, Henning SA, Scott SA, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy. Clin Pharmacol Ther. 2017;102(1):45\u201351. https:\/\/doi.org\/10.1002\/cpt.583.","journal-title":"Clin Pharmacol Ther"},{"key":"1159_CR12","doi-asserted-by":"publisher","unstructured":"Turan B, Kanmaz S, Turan C, Yazici P, Sim\u015fek E, Yurtseven A, et al. Efficacy and safety study of the revised Ege pediatric status epilepticus protocol (r-EPSEP). J Child Neurol. 2025 Jun 17:8830738251346214. https:\/\/doi.org\/10.1177\/08830738251346214.","DOI":"10.1177\/08830738251346214"},{"issue":"6","key":"1159_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/00000542-198012000-00010","volume":"53","author":"A Forster","year":"1980","unstructured":"Forster A, Gardaz JP, Suter PM, Gemperle M. Respiratory depression by midazolam and diazepam. Anesthesiology. 1980;53(6):494\u20137. https:\/\/doi.org\/10.1097\/00000542-198012000-00010.","journal-title":"Anesthesiology"},{"key":"1159_CR14","unstructured":"Dean L. Diazepam Therapy and CYP2C19 Genotype. In: Pratt VM, Scott SA, Pirmohamed M, et al., editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012\u2013. Updated 2020 Oct 15. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK379740\/."},{"issue":"1","key":"1159_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40360-024-00750-w","volume":"25","author":"P Li","year":"2024","unstructured":"Li P, Cao M, Liu L, Chen L, Liang S, Wang Y. Analysis of the effect of CYP2C19 gene properties on the anti-platelet aggregation of clopidogrel after carotid artery stenting under network pharmacology. BMC Pharmacol Toxicol. 2024;25(1):34. https:\/\/doi.org\/10.1186\/s40360-024-00750-w.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"1159_CR16","first-page":"1685","volume":"34","author":"H Wu","year":"2021","unstructured":"Wu H, Chen X, Ding Y, Deng Y, Ma R, Chen X, et al. Study on the effect of CYP2C19 genetic polymorphism and plasma concentration on clopidogrel resistance. Pak J Pharm Sci. 2021;34(5):1685\u201391. PMID:34803003.","journal-title":"Pak J Pharm Sci"},{"key":"1159_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jocn.2015.10.038","volume":"29","author":"W Wu","year":"2016","unstructured":"Wu W, Zhang L, Xue R. Lorazepam or diazepam for convulsive status epilepticus: A meta-analysis. J Clin Neurosci. 2016;29:133\u20138. https:\/\/doi.org\/10.1016\/j.jocn.2015.10.038.","journal-title":"J Clin Neurosci"},{"issue":"16","key":"1159_CR18","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2014.26254","volume":"311","author":"JM Chamberlain","year":"2014","unstructured":"Chamberlain JM, Okada P, Holsti M, Mahajan P, Brown KM, Vance C, et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA. 2014;311(16):1652\u201360. https:\/\/doi.org\/10.1001\/jama.2014.26254.","journal-title":"JAMA"},{"issue":"3","key":"1159_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12098-011-0505-y","volume":"79","author":"G Gathwala","year":"2012","unstructured":"Gathwala G, Goel M, Singh J, Mittal K. Intravenous diazepam, midazolam and lorazepam in acute seizure control. Indian J Pediatr. 2012;79(3):327\u201332. https:\/\/doi.org\/10.1007\/s12098-011-0505-y.","journal-title":"Indian J Pediatr"},{"issue":"7","key":"1159_CR20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.clinthera.2018.06.001","volume":"40","author":"BL Song","year":"2018","unstructured":"Song BL, Wan M, Tang D, Sun C, Zhu YB, Linda N, et al. Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese Subjects. Clin Ther. 2018;40(7):1170\u20138. https:\/\/doi.org\/10.1016\/j.clinthera.2018.06.001.","journal-title":"Clin Ther"},{"issue":"5","key":"1159_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/MCA.0000000000000092","volume":"25","author":"T Liu","year":"2014","unstructured":"Liu T, Yin T, Li Y, Song LQ, Yu J, Si R, et al. CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention. Coron Artery Dis. 2014;25(5):412\u201320. https:\/\/doi.org\/10.1097\/MCA.0000000000000092.","journal-title":"Coron Artery Dis"},{"issue":"1","key":"1159_CR22","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1080\/21655979.2021.1955809","volume":"12","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Gul S, Akhlaq M, Hussain A, Tariq Khan S, Rehman H, et al. Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome P450 2C19 gene in six major ethnicities of Pakistan. Bioengineered. 2021;12(1):4442\u201351. https:\/\/doi.org\/10.1080\/21655979.2021.1955809.","journal-title":"Bioengineered"},{"issue":"1","key":"1159_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/dmpt-2019-0026","volume":"35","author":"VY Skryabin","year":"2020","unstructured":"Skryabin VY, Zastrozhin MS, Torrado MV, Grishina EA, Ryzhikova KA, Shipitsyn VV, et al. How do CYP2C192 and CYP2C1917 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome? Drug Metab Pers Ther. 2020;35(1):1\u20138. https:\/\/doi.org\/10.1515\/dmpt-2019-0026.","journal-title":"Drug Metab Pers Ther"},{"issue":"11","key":"1159_CR24","doi-asserted-by":"publisher","first-page":"e25150","DOI":"10.1097\/MD.0000000000025150","volume":"100","author":"J Wang","year":"2021","unstructured":"Wang J, Kuang J, Yi Y, Peng C, Ge Y, Yin S, et al. Does CYP2C19 polymorphisms affect neurological deterioration in stroke\/TIA patients? A systematic review and meta-analysis of prospective cohort studies. Med (Baltim). 2021;100(11):e25150. https:\/\/doi.org\/10.1097\/MD.0000000000025150.","journal-title":"Med (Baltim)"},{"issue":"4","key":"1159_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2710.2007.00829.x","volume":"32","author":"T Fukasawa","year":"2007","unstructured":"Fukasawa T, Suzuki A, Otani K. Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. J Clin Pharm Ther. 2007;32(4):333\u201341. https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00829.x.","journal-title":"J Clin Pharm Ther"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01159-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01159-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:46:47Z","timestamp":1786589207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01159-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01159-3","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Ege University Faculty of Medicine with decision number 20-7.1T\/15 and was conducted in accordance with the Declaration of Helsinki and subsequent ethical standards. Written informed consent was obtained from the parents or legal guardians of all pediatric patients included in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"107"}}